Vanadium compounds in the treatment of elevated blood sugar levels
US5888993A · kind A · utility
6Cited by
4References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 3, 1997 |
| Grant date | Mar 30, 1999 |
| Priority date | — |
| Expiry date | Nov 3, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/555
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There are provided vanadium compositions for use in the treatment of hypertension, obesity and diabetes, in particular improved oral compositions comprising oxovanadium (IV) chelates of monoprotic, bidentate oxygen, oxygen and oxygen, nitrogen coordinating ligands especially kojic acid, maltol and ethyl maltol.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.